China’s Junshi Biosciences has licensed technology to produce an antibody against COVID-19 from Swiss biotechnology firm Lonza.
The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.
The COVID-19 pandemic poses unprecedented challenges to the biomedical community as it strives to find the best solutions to fight COVID-19.
The antitrust chief of the US Justice Department (DOJ) made a rare appearance in court when he requested that the US Court of Appeals for the Eleventh Circuit reject a defence used by a medical and dental board against an antitrust lawsuit.
Drug company Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the EU General Court ruled in favour of the European Union IP Office (EUIPO) yesterday, July 8.
A Roche subsidiary will be unable to block Amgen from producing the cancer drug Mvasi (bevacizumab), the Court of Appeals for the Federal Circuit has ruled.
The European Patent Office has unveiled data sets relating to antiviral vaccines and pharmaceutical therapeutics as part of its new “Fighting coronavirus” platform.
The Federal Court of Australia has upheld a patent victory for Indian generic manufacturer Sun Pharma over Mylan in a dispute over cholesterol drug fenofibrate.
US medical technology company CardioNet has lost an appeal at the US Court of Appeals for the Federal Circuit , which found its patents covered abstract concepts and therefore are invalid.
European law firm Carpmaels & Ransford has promoted Jennifer Antcliff to partner in its dispute resolution team in its London office, bringing the total number of partners in the team to five.